Group Written Exposure Therapy for PTSD
(GWET Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests the effectiveness of Written Exposure Therapy (WET) in a group setting for individuals with post-traumatic stress disorder (PTSD). It aims to determine if group WET reduces PTSD symptoms and results in fewer dropouts compared to Cognitive Processing Therapy (CPT). Participants will attend six online group sessions led by therapists and will report on their symptoms throughout the trial. Individuals with PTSD who can read and write in English may qualify, but those with certain mental health conditions or recent self-harm attempts are not eligible. The study will compare symptom changes over time between group WET and group CPT. As an unphased trial, it offers participants the chance to contribute to innovative research that could enhance PTSD treatment options.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that group Written Exposure Therapy is safe for PTSD patients?
Research shows that Written Exposure Therapy (WET) is generally safe and effective for treating PTSD. Studies indicate that even individuals with complex PTSD and other mental health issues respond well to WET. An initial study found that using WET in a group setting was practical and promising for reducing PTSD and depression symptoms. These studies reported no major negative effects, suggesting the therapy's safety for participants. Overall, increasing evidence supports WET's safety and effectiveness for treating PTSD.12345
Why are researchers excited about this trial?
Unlike traditional PTSD treatments like cognitive behavioral therapy (CBT) or medication, Group Written Exposure Therapy offers a unique approach by focusing on structured writing exercises in a group setting. Researchers are excited about this method because it encourages patients to process traumatic experiences through writing, which can be less intimidating than verbal therapy. Additionally, this therapy can be more accessible and cost-effective since it can be conducted in groups, potentially reaching more individuals in need.
What evidence suggests that Group Written Exposure Therapy might be an effective treatment for PTSD?
Research has shown that Written Exposure Therapy (WET) effectively treats PTSD. Studies have found that WET can reduce symptoms even in individuals with complex cases and other mental health issues. Evidence suggests that WET is practical due to its brief format of only five sessions, making it accessible to more people in need. Compared to other treatments, WET has successfully improved PTSD symptoms across various patient groups. It is considered a good option for those seeking a quick and effective PTSD treatment.12678
Who Is on the Research Team?
Jenna Boyd, Ph.D.
Principal Investigator
St. Joseph's Healthcare Hamilton
Are You a Good Fit for This Trial?
This trial is for adults aged 18-65 with PTSD who can read and write in English. They must be able to give informed consent. It's not clear what excludes someone from participating, but typically it would involve factors that could interfere with the treatment or data collection.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants attend 6 weekly sessions of group Written Exposure Therapy (WET) delivered online by two therapists
Follow-up
Participants are monitored for changes in PTSD symptoms and related measures at 1-month post-treatment
What Are the Treatments Tested in This Trial?
Interventions
- Group Written Exposure Therapy
Group Written Exposure Therapy is already approved in United States, European Union for the following indications:
- Posttraumatic Stress Disorder (PTSD)
- Posttraumatic Stress Disorder (PTSD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
St. Joseph's Healthcare Hamilton
Lead Sponsor